Gene therapy for human colorectal cancer cell lines with recombinant adenovirus 5 based on loss of the insulin-like growth factor 2 imprinting

By                        

International Journal of Oncology, Vol. 46, Iss. 4, 2015-01 ,pp. : 1759-1767

Spandidos Publications

Access to resources Recommend Favorite

p53 Gene Mutation Analysis and Antisense-Mediated Growth Inhibition of Human Ovarian Carcinoma Cell Lines

By Skilling J.S.   Squatrito R.C.   Connor J.P.   Niemann T.   Buller R.E.  

Gynecologic Oncology, Vol. 60, Iss. 1, 1996-01 ,pp. : 72-80

Academic Press

Access to resources Recommend Favorite

Growth Suppression of a Cervical Cancer Cell Line (TMCC-1) by the Human Wild-Type p53 Gene

By Zheng P.S.   Iwasaka T.   Ouchida M.   Fukuda K.   Yokoyama M.   Sugimori H.  

Gynecologic Oncology, Vol. 60, Iss. 2, 1996-02 ,pp. : 245-250

Academic Press

Access to resources Recommend Favorite

Growth Inhibition of Human Cervical Cancer Cells with the Recombinant Adenovirus p53 in Vitro

By Hamada K.   Zhang W.W.   Alemany R.   Wolf J.   Roth J.A.   Mitchell M.F.  

Gynecologic Oncology, Vol. 60, Iss. 3, 1996-03 ,pp. : 373-379

Academic Press

Access to resources Recommend Favorite

Suppression of Diacylglycerol Levels by Antibodies Reactive with the c-erbB-2 (HER-2/neu) Gene Product p185 c-erbB-2 in Breast and Ovarian Cancer Cell Lines

By Boente M.P.   Berchuck A.   Whitaker R.S.   Kalen A.   Xu F.-J.   Clarke-Pearson D.L.   Bell R.M.   Bast R.C.  

Gynecologic Oncology, Vol. 70, Iss. 1, 1998-07 ,pp. : 49-55

Elsevier

Access to resources Recommend Favorite